Delta-Fly Pharma, Inc. Logo

Delta-Fly Pharma, Inc.

Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.

4598 | T

Overview

Corporate Details

ISIN(s):
JP3549370009
LEI:
Country:
Japan
Address:
徳島市川内町宮島錦野37番地の5
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Delta-Fly Pharma, Inc. is a biopharmaceutical company specializing in the research and development of anticancer agents. The company utilizes its proprietary "Module Drug Development" concept to create innovative and "gentle" cancer treatments designed to have reduced side effects and be available at a reasonable price. Its development pipeline focuses on small molecule and RNA therapeutics for various cancers, including Acute Myeloid Leukemia. Delta-Fly Pharma's mission is to develop medicines that benefit cancer patients and society through its unique drug discovery approach.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:39
Interim Report
確認書
Japanese 8.9 KB
2025-11-14 07:35
Interim Report
半期報告書-第16期(2025/04/01-2026/03/31)
Japanese 206.9 KB
2025-06-27 08:44
Post-Annual General Meeting Information
臨時報告書
Japanese 24.4 KB
2025-06-27 08:39
Governance Information
内部統制報告書-第15期(2024/04/01-2025/03/31)
Japanese 23.0 KB
2025-06-27 08:34
Registration Form
確認書
Japanese 8.8 KB
2025-06-27 08:30
Registration Form
有価証券報告書-第15期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-04-14 08:30
Prospectus
有価証券届出書(組込方式)
Japanese 289.0 KB
2024-11-14 07:39
Interim Report
確認書
Japanese 8.9 KB
2024-11-14 07:36
Interim Report
半期報告書-第15期(2024/04/01-2025/03/31)
Japanese 180.2 KB
2024-10-07 08:00
Major Shareholding Notification
臨時報告書
Japanese 22.6 KB
2024-09-20 08:00
Registration Form
有価証券届出書(組込方式)
Japanese 326.2 KB
2024-09-11 08:00
Major Shareholding Notification
臨時報告書
Japanese 22.8 KB
2024-06-28 08:31
Post-Annual General Meeting Information
臨時報告書
Japanese 23.5 KB
2024-06-28 08:28
Registration Form
確認書
Japanese 8.8 KB
2024-06-28 08:25
Governance Information
内部統制報告書-第14期(2023/04/01-2024/03/31)
Japanese 22.6 KB

Automate Your Workflow. Get a real-time feed of all Delta-Fly Pharma, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Delta-Fly Pharma, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Delta-Fly Pharma, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.